Afurolol

This classification denotes a beta-adrenergic blocking agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier WQ1WRV49R9. European Medicines Agency schedules Afurolol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05283MIG. Afurolol generally arises in the molecular formula C15H21NO4. The term AFUROLOL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 33, no. 10 1979, list 19.) AFUROLOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. As of Q4 2014, AFUROLOL remains the US FDA Preferred Term for this commodity. Afurolol bears US NLM identifiers UMLS ID C2348000 and NCI Concept Code C72970. SMILES: O(CC(O)CNC(C)(C)C)C1C2C(COC2=O)CCC1.